Successful treatment of donor cell derived myelodysplastic syndrome with 5-azacytidine

Ann Biol Clin (Paris). 2017 Dec 1;75(6):713-714. doi: 10.1684/abc.2017.1293.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Male
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / etiology*
  • Tissue Donors*
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine